Zydus Lifesciences shares witnessed a spike on Thursday after the company said its board will meet on May 19 to consider a share buyback. The stock also gained momentum as Zydus announced a $166 million acquisition of US-based Assertio. Investor sentiment improved on expectations of capital return and strategic business expansion.
Metropolis Healthcare sees strong Q4 performance driven by specialty and preventive testing push
Metropolis Healthcare reported a strong Q4 with significant growth in revenue, patient volumes, and profitability, driven by a shift towards specialized and preventive diagnostics. The